Clearside Biomedicalincis A Clinical Stage Biopharmaceutical Company Based In Alpharettageorgiathe Company Focuses On Developing Innovative Treatments For Vision Impairmentparticularly Through Its Proprietary Ocular Microinjection Platformthis Technology Allows For Non Surgical Drug Delivery To The Back Of The Eyespecifically Targeting The Suprachoroidal Spacewhich Enhances The Treatment Of Various Ocular Conditions Clearside Has A Diverse Pipeline Of Products Aimed At Addressing Significant Eye Health Issuesits Marketed Productxiperetreats Uveitic Macular Edemaother Pipeline Products Include Cls Ax For Wet Age Related Macular Degenerationbel Sar For Choroidal Melanomaabbv Rgx 314 For Diabetic Retinopathyand Avoralstat For Diabetic Macular Edemathe Company Has Established Partnerships With Various Pharmaceutical Firms To Expand The Commercialization And Development Of Its Products Across Multiple Regionsenhancing Access To Its Innovative Therapies
